Carcinomas of the uterine cervix are thought to arise from preinvasive dysplastic lesions, termed cervical intraeplthelial neoplasias (CIN), grades I-ffl. Patients may present clinically with two or more distinct lesions of differing histo1o@ severity; however, the genesis of these multifocal lesions is unknown. Despite infection with high.risk human papilloma viiiis subtypes, which is a major etiological factor In disease pathogenesis, only a small and unpredictable number of dysplastic lesions progress to invasive cancer. Several lines of evidence suggest that additional somatic events, such as tumor suppressor gene inactivation, are required for malignant transformation. In support ofthis, loss ofheterozygoslty (LOH) analyses of invasive cervical carcinomas have identified several chromo somal arms likelyto harbor tumor suppressor genes,of which regions on 3p, 4p, 4q, and llq have been validated extensively. To evaluate the potential role oftumor suppressor gene inactivation in dysplastic progres shm, lod distributed on these four chromosomal regions were assessed for LOll in 42 CIN lesions of varying histological grade obtained from 17 patients. Analysis of at least 16 mlcrosateffite loci in each lesion revealed alldlic losses involving one or more ofthese chromosomal regions in 0% of CIN I lesions; 25% of CIN H lesions; and 88% of CIN LII lesions, with 41% of CIN ifi lesions exhibiting LOll for three or more chromosomal regions. In addition, where LOH was scored for the same locus at a particular chromosomal region in all of the multiple lesions from a single patleat, the same allele waslost at each locus, without exception. Statistical analysis of these allele-specific losses strongly suggests that topologically distinct lesions are related and likely arise from a common precursor celL
both to the accumulation of DNA damage following carcinogenic insult (6) and increased rates of cellular proliferation. Because only a minority of HPV-positive lesions progress to invasive cancer and generally do so over a long period of time, additional somatic events, which may include the functional inactivation of one or more tumor suppressor genes, are almost certainly required for malignant trans formation. Numerous studies based on somatic cell, cytogenetic, and LOH analyses strongly support this notion and have led to the local ization of putative tumor suppressor genes on several chromosomes, such as 3p (7â€"10), â€˜Ip, 4q (1 1, 12), 5p (13) , and 1lq (14â€"17),among others (18â€"20).Two studies, in addition, have included a limited number of dysplastic samples and have reported allelic losses on chromosomes 3p (8) and 5p (13) , implying that loss of function for tumor suppressor genes may occur early during cervical carcinogen esis. However, it is not clear if these losses are related to certain CIN phenotypes or how many such genes might be involved.
In a significant number of cases, patients diagnosed with cervical dysplasia present with multiple lesions of varying histological sever ity. Serial section analysis may reveal a single, deep lesion that has diffused laterally with focal extensions at the epithelial surface or, in many cases, may reveal multiple lesions that are distincfly separate entities. The genesis of these multifocal lesions is not understood but could conceivably arise as the result of a generalized â€oefield effect,â€• whereby continuous carcinogenic insults, such as HPV infection, may give rise to multiple, independently dysplastic cells. Alternatively, these lesions may be genetically related, having arisen from a single parental lesion and spread by cell migration to distant sites in the ectocervix.
To investigate the possible role of genetic alteration in the genesis and progression of cervical dysplasia and to understand the origin of multifocal cervical disease, 42 cervical lesions of varying histological grades derived from 17 patients were examined for allele-specific losses. Twenty-four microsatellite lcd were chosen to target regions on chromosomes 3p, 4p, 4q, and 1lq, which are known to undergo frequent alteration in invasive CC. In addition, the presence of HPV sequences and the specific subtypes involved were determined for each lesion and compared to patterns of observed LOH.
Materials and Methods
Patient Materials. Sixteen patients with two or more topologically distinct CINs and one patient with a single CIN II lesion were identified retrospectively from pathology reports filed between January 1994 and December 1995 at St. Joseph Hospital (Orange County, CA). The physical location of individual lesions within distinct quadrants of the cervix was confirmed by review of the colposcopy reports filed in each patient's medical record. A total of 42 formalin-fixed and paraffin-embedded lesions classified as 13 examined. Disease margins were marked on H&E-stained sections and used as a guide for the removal of normal, contaminating tissue using sterile scalpels and a X 10 dissecting microscope. After enrichment, dysplastic cells were removed from the slides using another scalpel and pooled. Normal, control tissues were scraped from slides as described above. DNA was prepared according to Mashal et a!. (21) City, CA) using the â€oeAmpliTaq Gold linkage mapping setâ€• conditions recom mended by the manufacturer. PCR products were analyzed by electrophoresis on an ABI model 373 sequencer (Applied Biosystems).
LOH Analysis. DNAs from normal tissue of each of the 17 patients were first tested for heterozygosity at 24 microsatellite loci distributed on chromo somes 3p, 4p, 4q, and llq (see Fig. 1 ) using six multiplex marker sets of four fluorescently labeled loci each. Homozygous, noninformative loci were re placed with other closely mapping loci to create four multiplex marker panels individualized for each set of multifocal dysplasias. Following amplification and electrophoresis, allelic products were assessed for peak height and peak area using GENESCAN and Genotyper (Applied Biosystems), and allelic ratios of heterozygous normal and lesion alleles were calculated as described previously (12, 22) .@LOH was assessed in all 42 CIN lesions at least two times independently; critical breakpoints were confirmed using coamplification of loci exhibiting LOH and nonsyntentic loci showing retention of heterozy gosity.
Identification of HPV Subtypes. Sequences of the HPV LI gene were detected using the MYO9IMYI1 primers (23) . Ten to 20 @.d of PCR product from positive lesions were digested with 10 units of RsaI (Stratagene, La Jolla, CA), and digestion productswere visualized on 3% Metaphoragarose gels. RsaI digestion allowed unequivocal determination of HPV subtypes 6b, I 1, 16, 18, and 33. For Ll products with unknown digestion patterns, full-length PCR products were isolated from the gel and directly sequenced using the MY1 1 primer on an ABI 373 or 377 automated DNA sequencer. Sequences were searched for database similarities using BLASTn. The HPV subtype was identified in each case with greater than 98% identity over a stretch of 300 to 350 nucleotides.
Results
Analysis of LOH in Cervical Dysplasia. Based on the observation of frequent LOH on chromosomes 3p, 4p, 4q, and 1lq in primary CCs (7â€"10, 12, 17, 18),@24 markers mapping within and flanking the most commonly altered regions on these chromosomal arms were chosen to evaluate LOH in DNAs prepared from 42 preinvasive lesions repre senting the entire histological spectrum of cervical dysplasia. To maximize the informativeness of this analysis, normal control DNAs from the 17 patients with multifocal disease were evaluated for heterozygosity at all 24 loci. Noninformative loci were replaced with closely mapping informative loci. Overall, the 42 lesions were as sessed with an average of 16 loci distributed on each of the three chromosomes ( High resolution analysis ofchromosome 3p alterations in cervical carcinoma, Cancer Res., 57: 4082â€"4090, 1997.
CIN lesions, and LOH data for loci on these three chromosomes in a set of 21 Stage lB squamous cell cervical carcinomas, is presented in Fig. 2 .
Allele-specific Losses in MU1tIfOCa1Cervical Lesions. A compar ison of LOH patterns in multiple lesions from the same patient revealed several cases where the same locus or group of loci showed LOH (Fig. lB) . Without exception, LOH in each of the multiple lesions involved the same allele from each locus. This is exemplified in Fig. 3 , which shows identical, allele-specific LOH for loci on chromosomes 3p, 4q, and llq in three topologically distinct CIN ifi lesions (Fig. 3) . Theoretically, for any locus that shows LOH, there is a 0.5:0.5 chance of observing loss from either the paternal or maternal allele in a heterozygous individual. The probability, P, of observing loss of the same allele in multiple, topologically distinct lesions is o.5nâ€" 1, where n is the number of lesions. In case 13, for example (Fig.  1B) , distinct regions of LOH occurred on 3p24.3, 3pl4.l, 4q, and llq. Each of these genetic events is probably independent, based on our previous observations in primary cancers that showed that losses on each of these three chromosomal arms can occur in any combination (0, 1,2,or 3 losses), andin addition, LOHfor multipleregions onthe same chromosome can also occur in any combination (12, 17) .@'@ Therefore, in case 13, the probability of loss of the same allele for loci on all four chromosomal regions is P = (O.25)@or 0.004. Of 17 patients, multifocal lesions from four cases, 13, 14, 16, and 17, exhibited allele-specific losses with individual probabilities of 0.004, 0.125, 0.25, and 0.125, respectively. The overall likelihood of observ ing these allele-specific losses by chance alone is the product of the individual probabilities, P = 1 X i0@. This strongly suggests that topologically distinct cervical lesions are genetically related and arise from at least a very few precursor cells.
Human Papifioma Viral Subtypes in Cervical Dysplasia. HPV subtypes were typically determined by PCR amplification of the Li gene followed by restriction digestion with RsaI. In some cases, the Ll PCR product was directly sequenced, and in other cases, the subtype identity was confirmed using both methods. Of the 42 lesions tested, HPV sequences were found in 36 (84%). The specific HPV subtypes determined for each lesion are shown in Table 1 (26, 27) . These biological markers, alone or in combination, however, are not predictive of the behavior of an individual lesion. In an attempt to identify potentially early events that may correlate with dysplastic progression, we evaluated LOH at loci on chromosomes 3p, â€˜4p, 4q, and 1lq in 42 dysplastic lesions of all grades obtained from 17 patients. Among the 13 CIN I lesions examined in this study, no evidence of LOH was found for any of the loci examined, which may, in part, be explainedby the fact that CIN I lesionsappearto be composedof two distinct entities: a group of polyclonal lesions generally associated with nonaggressive HPV subtypes (probably productive viral infec tions); and a group of monoclonal lesions, generally associated with aggressive HPV subtypes (24) . Of the 9 CIN I lesions containing HPV sequences, 7 were infected with low-risk subtypes and, therefore, probably represent reactive, polyclonal proliferations. At least in this study, therefore, we cannot draw any conclusions with respect to LOH in mild dysplasia on chromosomes 3p, 4, and 1lq. In contrast, LOH was observed in 3 of 12 CIN II lesions (25%). Eleven of the 12 CIN II lesions examined in this study were found to be infected with aggressive HPV subtypes and are likely to be monoclonal in origin and, therefore, evaluable for LOH. Thus, the numbers of LOH events reported here are likely to be an accurate reflection of the frequency of LOH on the chromosomal regions studied. A review of data summaries generated by almost 100 prospective follow-up studies determined that approximately 22% of CIN II lesions are likely to progress in histological severity. Although perhaps coincidental, it is noteworthy that this frequency of CIN II progression (22%) and the frequency of LOH in CIN II lesions (particularly for lcd on chromo some 3p, i.e., 25%) are so similar. However, any potential correlation would need to be addressed with significantly larger numbers of samples and analysis of additional marker loci genome-wide. LOH was found to be very frequent in CIN III lesions, with LOH for one increasing in frequency from 25% in CIN II to 82% in CIN III. Alterations of 3p were also observed as the sole event in two of the three CIN H lesions with LOH for any of the loci examined. Thus, it appears that alterations on this chromosomal arm may precede alter ations on chromosomes 4 and I lq. Three regions were commonly affected; 3pterâ€"3p24; 3pl4.2, and 3p14.lâ€"l2, which essentially agrees with our analyses of 3p losses in primary CC and CC-derived The highest frequency of LOH was observed for loci on 3p, cell lines.4 However, our analyses of primary CC has shown that over or more loci occurring in 88% of cases, of which 41% showed LOH for three or more of the chromosomal arms examined. sion of cervical dysplasia and invasive cancer. This hypothesis is directly testable, and integration may prove to be a marker of cells with a high degree of genetic change, of which a subset may be at greater risk for progression to invasive cancer. Identification of the latter will require analysis of lesions of all grades for LOH genome wide.
This study was designed, in addition, to ascertain the relationship between multifocal cervical dysplasias from individual patients, an important question that has not yet been addressed by molecular analysis. In cases where we observed LOH for the same locus or group of loci in each of the lesions from a single patient, the same allele was lost at each locus, without exception. Statistical analysis of the probability of observing such allele-specific losses in multifocal lesions from four individuals (P = 0.00001) strongly suggests that at least in evaluable patients, such multifocal lesions are genetically related. We suggest that such lesions likely arise from single precursor lesion, a result analogous to that found in patients with multiple preinvasive lesions of the bladder (3) and head and neck (34) , and that cells from the lesion of origin spread to other sites in the ectocervix by epithelial cell spread and thereafter evolve independently. 70% of individual tumors exhibit loss of multiple, distinct regions of this chromosome, making the identification of tumor suppressor genes relevant to CC difficult.4 In contrast, the patterns of allelic loss in dysplasia were relatively simple. Thus, analysis of 3p losses in a larger number of CIN Il/CIN III lesions with a larger number of loci may allow a clearer interpretation of the the role of relevant tumor suppressor loci and lead to further genomic sublocalization. LOH on chromosome 4 in dysplasia supported our previous localization of putative tumor suppressor genes to 4p and 4q in primary cancers (12) and also allowed us to refine the position of these two genes to 4pter-D4S403 and D4S426-4qter. Severe dysplasia is generally associated with an increase in DNA index and aneuploidy as compared to CIN II and CIN I lesions, respectively (26, 27) . This increase in genomic instability is both consistent with the fact that the E6 protein of aggressive subtypes is known to bind p53 and mediate its degradation through a ubiquitin dependent pathway (5) and with the observation that transfection of E6, but not E7, into uroepithelial cells leads to genome instability (28) . The foregoing suggests that genomic instability and conse quently, aneuploidy, are likely to be mediated through disruption of p53 gene activity. However, the E6 gene is transcriptionally repressed by the E2 gene when the virus is in an episomal form, a form that is found in the majority of CIN I lesions. In contrast, several reports suggest that integration of the viral genome increases with increasing grade of dysplasia (29, 30) . In the vast majority of cases, integration disrupts a large part of the El gene and/or the 5' end of the E2 gene, leaving E6 and E7 intact without transcriptional repression (31, 32). We speculate that the dramatic increase in the frequency of LOH seen in the transition from CIN H to CIN ifi may reflect a similarly dramatic increase in viral integration events, ultimately leading to inactivation of the p53 gene. The subsequent accumulation of genetic damage, as evidenced by aneuploidy and LOH analyses, is likely to occur on occasion in tumor suppressor genes critical to the progres 4175 
